CSIMarket
 


Inhibitor Therapeutics Inc   (HPPI)
Other Ticker:  
 

Cumulative Inhibitor Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period

HPPI's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

HPPI Quick Ratio for Trailing Twelve Months Period

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Growth -95.3 % -88.46 % 70.38 % 158.88 % 145.66 %
Y / Y Cash & cash equivalent Growth 40390.39 % 35108.45 % 22328.03 % -43.38 % -70.37 %
Quick Ratio for Trailing Twelve Months Period 17.41 8.21 3.57 0.05 0.08
Total Ranking # 101 # 340 # 906 # 4336 # 5031
Seq. Current Liabilities Growth -44.04 % -88.44 % -37.59 % 16.33 % 37.58 %
Seq. Cash & cash equivalent Growth -6.33 % -9.78 % 22424.83 % 112.7 % -18.55 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2023
On the trailing twelve months basis Inhibitor Therapeutics Inc Cash & cash equivalent average more than doubled by 40390.39% in II. Quarter year on year, while Current Liabilities plummeted to $ 0 millions, this led to increase in in Inhibitor Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period to 17.41, Quick Ratio for Trailing Twelve Months Period remained below Inhibitor Therapeutics Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry Inhibitor Therapeutics Inc achieved highest Quick Ratio for Trailing Twelve Months Period. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about HPPI
Quick Ratio HPPI in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 0
Sector # 0
S&P 500 # 1


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
17.41 3.48 0.05
(Jun 30 2023)   (Sep 30 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Structure Therapeutics Inc   43.73 
Xbiotech Inc   43.42 
Nuvation Bio Inc   43.35 
Acelyrin Inc   42.49 
Turning Point Therapeutics Inc.  41.31 
Synaptogenix Inc   40.01 
Atea Pharmaceuticals Inc   37.22 
Merrimack Pharmaceuticals Inc  36.76 
Rezolute Inc   35.20 
Karuna Therapeutics Inc   35.11 
Atossa Therapeutics Inc   34.14 
Design Therapeutics Inc   33.92 
Moonlake Immunotherapeutics  33.02 
Oramed Pharmaceuticals Inc   32.68 
Disc Medicine Inc   32.54 
Theseus Pharmaceuticals Inc   32.28 
Xenon Pharmaceuticals Inc   31.19 
Morphic Holding inc   31.12 
Ars Pharmaceuticals Inc   29.92 
Dice Therapeutics Inc   26.51 
Astria Therapeutics inc   25.48 
Savara Inc   25.23 
Eqrx Inc   25.12 
Briacell Therapeutics Corp   25.08 
Nanoviricides inc   24.69 
Kezar Life Sciences Inc   24.35 
Cyteir Therapeutics Inc   23.78 
Edgewise Therapeutics inc   23.52 
Imago Biosciences Inc   23.34 
Kura Oncology Inc   23.02 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com